Xiao Xu

Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study

David Price, Frank Trudo, Jaco Voorham et al. · Journal of Asthma and Allergy · 2018 · 479 citations · Full text

Public Health, Internal Medicine, Pharmacotherapy +14

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study

Christopher E. Brightling, Eugene R. Bleecker, Reynold A. Panettieri et al. · The Lancet Respiratory Medicine · 2014 · 314 citations

Medicine, Immunology, Pharmacotherapy +14

Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma

Jaco Voorham, Xiao Xu, David Price et al. · Allergy · 2018 · 119 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +12

The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies

Mitchell Goldman, Ian Hirsch, James Zangrilli et al. · Current Medical Research and Opinion · 2017 · 92 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study

Sigrún Alba Jóhannesdóttir Schmidt, Martin Berg Johansen, Morten Olsen et al. · BMJ Open · 2014 · 84 citations · Full text

Medicine, Chronic Disease Control, Epidemiologic Methods +14